Ropes & Gray represented Black Diamond Therapeutics in the transaction. Black Diamond Therapeutics (Nasdaq: BDTX) announced a global licensing agreement with French pharmaceutical company Servier for...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented FibroGen, Inc. in the transaction. FibroGen, Inc. (NASDAQ: FGEN) announced the sale of its China subsidiary, Fibrogen China, to AstraZeneca for approximately...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Brahma and the DNEG Group in the transaction, and Simpson Thacher & Bartlett represented Metaphysic Inc. Brahma, a global AI and content...
You must be a Standard 1 Year member to access this content.
DLA Piper, Ropes & Gray and Simpson Thacher Bartlett served as legal advisors to the KKR and Baupost joint venture, while Burges Salmon as legal counsel...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Arrowhead Pharmaceuticals, Inc. on the transaction, and Ropes & Gray advised Sarepta Therapeutics. Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a global...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Apollo Therapeutics in the transaction. Apollo Therapeutics Group Limited (“Apollo”) and Sunshine Lake Pharma Co., Ltd. have entered into an exclusive license...
You must be a Standard 1 Year member to access this content.
Ropes & Gray, and Polsinelli are serving as advisors to H.I.G. and Thoma Bravo, while Husch Blackwell is serving as legal advisor to Comptia. H.I.G. Capital...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Bluecat Networks in the transaction. Bluecat Networks (BlueCat) announced its acquisition of LiveAction, a global provider of network observability and intelligence solutions....
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher advised Insight Partners on the deal, and Ropes & Gray advised HarbourVest Partners. Insight Partners announced the closing of Continuation Fund III,...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Vir Biotechnology in the transaction. Vir Biotechnology (Nasdaq: VIR) announced it has entered into an exclusive worldwide license agreement with Sanofi for...
You must be a Standard 1 Year member to access this content.
